Themis Medicare Limited (THEMISMED)
₹264.45
INR+2.90(+1.11%)
As of December 26, 2024 9:56:00 AMAbout Themis Medicare Limited
Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. The company offers active pharmaceutical ingredients (APIs) and formulations for use in various therapeutic areas, including anti-tuberculosis, anti-malarials, cardiology, pain management, anti-infectives, haematinics, health and nutrition, anaesthesia, gynecology, and orthopedics. It also offers anti-inflammatory drugs and other drugs. The company was formerly known as Themis Chemicals and changed its name to Themis Medicare Limited in 2001. Themis Medicare Limited was founded in 1952 and is headquartered in Mumbai, India.
RevenueLast 12 months
NA
+NA YoY
Total revenue generated from all business operations over the last 12 months
EBITDALast 12 months
NA
Earnings Before Interest, Taxes, Depreciation, and Amortization - a measure of company's operating performance
Price to Sales RatioTTM
5.88
Compares a company's stock price to its revenues. Lower ratio might indicate an undervalued stock
Operating MarginLast 12 months
12.54
+26.3% quarterly YoY
Operating income as a percentage of revenue, indicating operational efficiency
Market Cap
2472.66 CrINR
Total market value of the company's outstanding shares
Employees
1509
Total number of full-time employees worldwide
CEO
Dr. Sachin Dinesh Patel CChem., Ph.D.
Chief Executive Officer of the company